VyrarX Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: compounded sema $179/mo, tirz $329/mo; LegitScript-certified, 47 states
VyrarX scores highest on coaching and ongoing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians. Every plan includes 1:1 direct provider messaging, a personalized titration plan, nutrition coaching, and free direct-to-door shipping. Provider reviews are completed within 24 hours of intake. No insurance is needed and services are available in 47 states.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to VyrarX
Editorial score · methodology
Sprout Health
Best for: LegitScript-verified compounded GLP-1 via named pharmacies
Editorial score · methodology
PeterMD
Best for: men wanting flat-priced compounded GLP-1 with TRT or peptides
Editorial score · methodology
VyrarX at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- What's included
- Medication · Consult · Shipping · Coaching
- FDA status
- No FDA warning letter on record
How we scored VyrarX
Each dimension is scored algorithmically from VyrarX’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.5/10At $179/mo, VyrarX runs about 6% above the $169 median for GLP-1 providers.
Effectiveness25%
7.8/10VyrarX offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.5/10Online intake and platform experience — ongoing clinician messaging, consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-02).
Accessibility10%
5.8/10VyrarX's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
8.0/10Coaching/dietitian access included, clinician messaging between visits.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this VyrarX review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with VyrarX
We walked VyrarX’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a 5-minute medical questionnaire from your phone.
- 2A licensed US physician reviews your history within 24 hours.
- 3Approved medication is shipped to your home.
- 4Ongoing messaging support with regular check-ins.
- Monthly pricing shown up front: Semaglutide from $179/mo, Tirzepatide from $329/mo.
- States it operates in 47 states and no insurance is needed.
- Free shipping is advertised as a standard benefit.
- A refund policy is linked separately but not detailed on the page.
- Support appears to be email-only with no phone number or hours listed.
VyrarX customer support
- care@vyrarx.com
GLP-1 medications VyrarX offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Verbatim from homepage: 'From $179/mo'. Compounded semaglutide injection; 'From' price is entry-tier, maintenance-dose pricing not publicly disclosed. Includes free shipping and 1:1 provider messaging.
Verbatim from homepage: 'From $329/mo'. Compounded tirzepatide injection; 'From' price is entry-tier, maintenance-dose pricing not publicly disclosed. Includes free shipping and 1:1 provider messaging.
Ready to get started?
Plans and promotions change often — check VyrarX's current pricing and active discounts before you decide.
What we like
- LegitScript certified with active seal (ID 51177727)
- Semaglutide starting at $179/month with free shipping included
- 1:1 direct provider messaging and personalized titration plan in every plan
- Nutrition coaching included with the weight-loss program
- Provider review completed within 24 hours; no insurance required
Watch-outs
- Tirzepatide at $329/month starting is at the high end of the compounded market
- Compounding pharmacy not named on any public page
- No physician names or clinical leadership disclosed publicly
- Only 47 states covered — the 3 excluded states are not named on the site
- Labs not included in the weight-loss plan
Is VyrarX worth it? Our verdict
VyrarX positions itself around one thing: compounded sema $179/mo, tirz $329/mo; LegitScript-certified, 47 states. It runs $179/month. Coaching and follow-up are part of the package, not an upsell.
What gives VyrarX its own flavor: LegitScript certified, 47-state coverage, and 1:1 provider messaging.
How much VyrarX actually costs
- Compounded semaglutide — $179/month
- Compounded tirzepatide — $329/month
That's roughly in line with the ~$169/month median across the GLP-1 providers we track.
For a direct comparison, DudeMeds runs semaglutide and tirzepatide from $175/month — worth pricing against VyrarX before you commit.
Medications: what VyrarX prescribes
VyrarX prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who VyrarX is best for — and who should skip it
A good fit if you…
- want coaching and follow-up included, not sold separately.
- value being able to message a clinician between visits.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
VyrarX offers clinician messaging between visits. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
VyrarX is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. If you're comparison-shopping, Bodybuilding Health+ is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
VyrarX scores highest on coaching and ongoing support.
Ready to start with VyrarX?
Starting at $179/month. See current pricing and start your free consultation.
VyrarX might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this VyrarX review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See VyrarX's current pricing
Plans start at $179/month. Start your free consultation to check eligibility and today's price.